Which Gene is a Dominant Predictor of Response During FOLFOX Chemotherapy for the Treatment of Metastatic Colorectal Cancer, the MTHFR or XRCC1 Gene?

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Aimery de Gramont, Arié Figer, Michel Seymour et al. · Journal of Clinical Oncology · 2000 · 3.8K citations

Medicine, Oncology, Pharmacotherapy +11

Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer

Yuman Fong, Joseph G. Fortner, Ruth L. Sun et al. · Annals of Surgery · 1999 · 3.7K citations · Full text

Medicine, Oncology, Surgery +17

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton et al. · Journal of Clinical Oncology · 2003 · 2.3K citations

Medicine, Oncology, Pharmacology +15

Resection of colorectal liver metastases

Johannes Scheele, Richard Stang, A. Altendorf-Hofmann et al. · World Journal of Surgery · 1995 · 1.5K citations

Medicine, Oncology, Surgery +12

Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer

Sylvie Giacchetti, B Perpoint, Rachid Zidani et al. · Journal of Clinical Oncology · 2000 · 1.4K citations

Medicine, Oncology, Pharmacology +14